Trexquant Investment LP Regeneron Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 13,951 shares of REGN stock, worth $10.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

13,951

Holding current value

$10.3 Million

% of portfolio

0.19%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $14.3 Million - $16.8 Million	13,951 New	13,951 $14.7 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $4.57 Million - $5.19 Million	5,891 New	5,891 $5.17 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.33 Million - $1.56 Million	-2,230 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $4.69 Million - $5.79 Million	-8,625 Reduced 79.46%	2,230 $1.41 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $6.23 Million - $7.39 Million	10,855 New	10,855 $6.57 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $1.66 Million - $2.04 Million	-3,717 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $1.78 Million - $2.26 Million	3,717 New	3,717 $1.8 Million
Q1 2020 May 08, 2020	SELL	$336.18 - $494.43 $665,636 - $978,971	-1,980 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $1.84 Million - $2.53 Million	-6,722 Reduced 77.25%	1,980 $743,000
Q3 2019 Nov 08, 2019	BUY	$273.46 - $318.39 $294,242 - $342,587	1,076 Added 14.11%	8,702 $2.41 Million
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $2.28 Million - $3.16 Million	7,626 New	7,626 $2.39 Million
Q2 2018 Aug 07, 2018	SELL	$284.6 - $344.99 $1.14 Million - $1.39 Million	-4,022 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$315.82 - $393.78 $1.97 Million - $2.46 Million	-6,253 Reduced 60.86%	4,022 $1.39 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $3.68 Million - $4.83 Million	10,275	10,275 $3.86 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Regeneron Pharmaceuticals, Inc. Transaction History